Frontlight ResearchEarly access
Trial site
University of Oklahoma Health Sciences Center, Stephenson Cancer Center
- 5running trials
- 6closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Endometrial cancer3 trials
- Ovarian cancer2 trials
- Prostate cancer2 trials
- Chronic lymphocytic leukaemia1 trial
- Crohn's disease1 trial
- Head and neck cancer1 trial
- Liver and biliary tract cancer1 trial
- Metastatic breast cancer1 trial
- Phase
- Phase 23 trials
- Phase 33 trials
- Phase 12 trials
- Phase 1/21 trial
- Status
- Terminated5 trials
- Active, not recruiting4 trials
- Completed1 trial
- Not yet recruiting1 trial
- Lead sponsor
- University of Oklahoma4 trials
- Eli Lilly and Company2 trials
- Coherus Oncology, Inc.1 trial
- EMD Serono Research & Development Institute, Inc.1 trial
- Juno Therapeutics, a Subsidiary of Celgene1 trial
- and 2 more
Running trials
Recruiting
Active, not recruiting
Sipuleucel-T Based Autologous Cellular Immunotherapy for Advanced Prostate Cancer
Active, not recruiting
Active, not recruiting
A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Ovarian cancer1 recruiting
Closed trials
Terminated
Terminated
Terminated
Terminated
Completed
Terminated
Site data: ClinicalTrials.govUpdated 17 Nov 2026